English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  50703476    線上人數 :  339
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"junmin"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 1-11 / 11 (共1頁)
1 
每頁顯示[10|25|50]項目

機構 日期 題名 作者
國立成功大學 2024-11-5 The Association between Glucagon-like Peptide-1 Receptor Agonist and Major Adverse Cardiac and Cerebrovascular Events in Monoclonal Gammopathy of Undetermined Significance: A Propensity-Score Analysis Song;Junmin;Deshpande;Ravindra, Shweta;Chang;Yu-Cheng;Chiang;Cho-Han;Ahn;Jaeun;Lessa;Caceres, Ana Yasmin;Soni;Anushri;Gonzales;Anthony;Lee;Pei-Lun;Chang;Yu;Parker;Terri, L.;Kwan;Jennifer;Chi;Kuan-Yu;Nanna;Michael, G.
國立成功大學 2024-11-5 Comparative Venous and Arterial Thromboembolism Profiles Associated with Different Cyclin-Dependent Kinase 4/6 Inhibitors: A Real-World Study Chiang;Han, Cho;Lin;Shuwen;Chang;Yu-Cheng;Song;Junmin;Chi;Kuan-Yu;Xanthavanij;Nutchapon;Chang;Yu;Chiang;Cho-Hung;Xu;Haze, Xiaocao
國立成功大學 2024-11-5 The Association between Combination-Based Immunotherapy and Thrombotic Events in Patients with Metastatic Renal Cell Carcinoma Chang;Yu-Cheng;Chiang;Cho-Han;Tamdin;Tenzin;Song;Junmin;Chang;Yu;Chi;Kuan-Yu;Peng;Chun-Yu;Gao;Wenli
國立成功大學 2024-11-05 Comparative Outcomes of Immune Checkpoint Inhibitor and Chemotherapy in Lung Cancer Patients: A Multi-Ethnic Retrospective Analysis Tamdin;Tenzin;Chiang;Cho-Han;Song;Junmin;Chang;Yu;Chi;Kuan-Yu;Peng;Chun-Yu;Chang;Yu-Cheng
國立成功大學 2024-11-05 Anticoagulation for Patients with Essential Thrombocythemia or Polycythemia Vera-Associated Venous Thromboembolism Tamdin;Tenzin;Chang;Yu-Cheng;Chiang;Cho-Han;Song;Junmin;Chi;Kuan-Yu;Chang;Yu;Peng;Chun-Yu;Gao;Wenli
國立成功大學 2024-11-05 Real-World Validation of the Khorana Risk Score in Predicting Thrombosis for Lung Cancer Patients Treated with Immune Checkpoint Inhibitors Song;Junmin;Chang;Yu-Cheng;Ahn;Jaeun;Chi;Kuan-Yu;Chang;Yu;Chiang;Cho-Han
國立成功大學 2024-11-05 Khorana Risk Score for Thrombosis Prediction in Patients with Gynecologic Malignancies Using Immune Checkpoint Inhibitors- a Real-World Validation Song;Junmin;Chang;Yu-Cheng;Abram;Diaz, Ana Maria;Ahn;Jaeun;Chi;Kuan-Yu;Chang;Yu;Chiang;Cho-Han
國立成功大學 2024-10 The association between pembrolizumab and risk of venous thromboembolism in patients with breast cancer Chiang;Cho-Han;Xu;Xiaocao;Song;Junmin;Xanthavanij;Nutchapon;Chi;Kuan-Yu;Chang;Yu-Cheng;Chang;Yu;Hsiao;Chieh-Lien;Chiang;Cho-Hung;Lin;Shuwen
國立成功大學 2024-10 Association Between GLP-1 Receptor Agonists and Incidence of Lung Cancer in Treatment-Na�ve Type 2 Diabetes Song;Junmin;Daylan;Cali, Ayse Ece;Chi;Kuan-Yu;Anand;Prem, Dharshana;Chang;Yu;Chiang;Cho-Han;Cheng;Haiying
國立成功大學 2024-08 The comparative efficacy and safety of factor Xa inhibitors and warfarin for primary thromboprophylaxis in multiple myeloma patients undergoing immunomodulatory therapy Chang;Yu-Cheng;Song;Junmin;Chi;Kuan-Yu;Gao;Wenli;Chang;Yu;Chiang;Cho-Hung;Hsia;Ping, Yuan;Chiang;Cho-Han
國立成功大學 2024-06-1 Risk factors for thrombotic events among patients taking immune checkpoint inhibitors: A systematic review and meta-analysis. Song;Junmin;Lessa;Caceres, Ana Yasmin;Lee;Pei-Lun;Chowdhury;Ishmum;Chang;Yu;Chang;Yu-Cheng;Schwartz;Rachel;Chi;Kuan-Yu;Kumar;Abhishek

顯示項目 1-11 / 11 (共1頁)
1 
每頁顯示[10|25|50]項目